Clinical Trial Detail

NCT ID NCT03404193
Title Venetoclax in Combination With 10-Day Decitabine in Newly Diagnosed Elderly or Relapsed/Refractory Acute Myeloid Leukemia and Relapsed High-risk Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

acute myeloid leukemia

acute leukemia

chronic myelomonocytic leukemia

myelodysplastic syndrome


Decitabine + Venetoclax

Age Groups: adult senior

No variant requirements are available.